It disables NF-κB via PKC- and PI3K/Akt-mediated Nrf2 activation in human dermal microvascular endothelial cells (HMEC-1), preventing lipopolysaccharide-evoked endothelial dysfunction from acute inflammation [30]. This evidence concerns the gene AKT1 and endothelial dysfunction.